2023-03-30T16:58:22+08:00 weekly 1.0 https://ht.prisysbiotech.com/ 2024-11-13T15:00:33+08:00 weekly 0.9 https://ht.prisysbiotech.com/animal-welfare 2024-11-13T15:00:32+08:00 weekly 0.9 https://ht.prisysbiotech.com/translational-research-center 2024-11-13T15:00:50+08:00 weekly 0.9 https://ht.prisysbiotech.com/ophthalmic-disease-research 2024-11-13T15:00:35+08:00 weekly 0.9 https://ht.prisysbiotech.com/respiratory-disease-research 2024-11-13T15:00:40+08:00 weekly 0.9 https://ht.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-13T15:00:34+08:00 weekly 0.9 https://ht.prisysbiotech.com/metabolic-syndromes-research 2024-11-13T15:00:17+08:00 weekly 0.9 https://ht.prisysbiotech.com/hematological-disease-research 2023-04-01T22:59:55+08:00 weekly 0.9 https://ht.prisysbiotech.com/co-develop 2024-11-13T15:00:44+08:00 weekly 0.9 https://ht.prisysbiotech.com/inflammation-immunology-disorders 2024-11-13T15:00:32+08:00 weekly 0.9 https://ht.prisysbiotech.com/download 2024-11-13T15:00:45+08:00 weekly 0.9 https://ht.prisysbiotech.com/fibrosis 2024-11-13T15:00:52+08:00 weekly 0.9 https://ht.prisysbiotech.com/nephrology 2024-11-13T15:00:38+08:00 weekly 0.9 https://ht.prisysbiotech.com/about-us 2024-11-13T15:00:38+08:00 weekly 0.9 https://ht.prisysbiotech.com/contact-us 2023-04-01T22:59:56+08:00 weekly 0.9 https://ht.prisysbiotech.com/newslist-1 2024-11-13T15:00:29+08:00 weekly 0.9 https://ht.prisysbiotech.com/products 2023-04-01T22:41:08+08:00 weekly 0.9 https://ht.prisysbiotech.com/safety-evaluation/ 2023-04-01T22:41:09+08:00 weekly 1.0 https://ht.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T22:41:09+08:00 weekly 0.9 https://ht.prisysbiotech.com/biosafety-research/ 2023-04-01T22:41:09+08:00 weekly 0.9 https://ht.prisysbiotech.com/translation-research/ 2023-04-01T22:41:10+08:00 weekly 0.9 https://ht.prisysbiotech.com/pk-pd-adme/ 2024-04-10T02:55:03+08:00 weekly 0.9 https://ht.prisysbiotech.com/clearpoint/ 2024-11-13T15:00:24+08:00 weekly 0.8 https://ht.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-13T15:00:26+08:00 weekly 0.8 https://ht.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-04-01T22:59:43+08:00 weekly 0.8 https://ht.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2023-04-01T22:59:44+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-13T15:00:51+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-11-13T15:00:27+08:00 weekly 0.8 https://ht.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-04-01T22:59:47+08:00 weekly 0.8 https://ht.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-13T15:00:16+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-13T15:00:32+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2024-11-13T15:00:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2023-04-01T22:59:52+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-13T15:00:30+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-04-01T22:59:49+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-13T15:00:23+08:00 weekly 0.8 https://ht.prisysbiotech.com/translation-research/nhpresources.html 2023-04-01T22:59:44+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-04-01T22:59:49+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-04-01T22:59:47+08:00 weekly 0.8 https://ht.prisysbiotech.com/translation-research/translational-studies.html 2023-04-01T22:59:49+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-13T15:00:25+08:00 weekly 0.8 https://ht.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-13T15:00:31+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2024-11-13T15:00:53+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-04-01T22:59:50+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2023-04-01T22:59:50+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-04-01T22:59:49+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2024-11-13T15:00:53+08:00 weekly 0.8 https://ht.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-13T15:00:36+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2024-11-13T15:00:27+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2023-04-01T22:59:50+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-04-01T22:59:48+08:00 weekly 0.8 https://ht.prisysbiotech.com/safety-evaluation/toxicology.html 2023-04-01T22:59:51+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-04-01T22:59:49+08:00 weekly 0.8 https://ht.prisysbiotech.com/pk-pd-adme/adme.html 2023-04-01T22:59:51+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-13T15:00:39+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-13T15:00:30+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-13T15:00:29+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-04-01T22:59:49+08:00 weekly 0.8 https://ht.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2023-04-01T22:59:49+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-13T15:00:44+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-13T15:00:31+08:00 weekly 0.8 https://ht.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-13T15:00:53+08:00 weekly 0.8 https://ht.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-13T15:00:46+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-13T15:01:17+08:00 weekly 0.8 https://ht.prisysbiotech.com/translation-research/clinical-imaging.html 2024-10-06T08:22:02+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-10-06T08:22:06+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-10-06T08:22:07+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-10-06T08:22:10+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-10-06T08:22:18+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-13T15:00:34+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-10-06T08:22:20+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-12-04T12:00:58+08:00 weekly 0.8 https://ht.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-04T12:00:59+08:00 weekly 0.8 https://ht.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-04-01T18:01:38+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-01T18:01:38+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-25T14:38:56+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-25T14:39:02+08:00 weekly 0.8 https://ht.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-26T17:17:48+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-17T01:46:46+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-24T08:05:20+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-10-02T12:30:01+08:00 weekly 0.8 https://ht.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-08T10:39:40+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T10:22:58+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T18:23:26+08:00 weekly 0.8 https://ht.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2023-04-01T22:59:39+08:00 weekly 0.9 https://ht.prisysbiotech.com/newslist-714647-1 2023-04-01T22:59:39+08:00 weekly 0.9 https://ht.prisysbiotech.com/newslist-714648-1 2024-08-03T21:48:29+08:00 weekly 0.9 https://ht.prisysbiotech.com/newslist-820089-1 2023-04-01T22:59:42+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/meetprisys-sot2023-66158567.html 2023-04-01T22:59:43+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66158568.html 2023-04-01T22:59:42+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66158569.html 2023-04-01T22:59:43+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-sot2023-66158570.html 2023-04-01T22:59:43+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/gene-therapy-nhp-model-66158571.html 2023-04-01T22:59:45+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66158572.html 2023-04-01T22:59:43+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66158573.html 2023-04-01T22:59:45+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66158574.html 2023-04-01T22:59:46+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66158575.html 2023-04-01T22:59:47+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66158576.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/gene-therapy-toxicology-66279048.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67576724.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/world-parkinsons-disease-day-67576725.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67580376.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67580377.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67580378.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67587927.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67596030.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67598663.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68134335.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68134337.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68134350.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68134395.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68307023.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69086510.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69086820.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69086825.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69087565.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69090741.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69091687.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309265.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309331.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309340.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309356.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69671801.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69671897.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71030161.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/0-71030279.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71030288.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71030434.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71030515.html 2023-09-15T01:36:46+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71030579.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72337980.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72337981.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72337982.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72337983.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72337984.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72718083.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73036172.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73857318.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73857624.html 2024-01-15T12:37:01+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74227985.html 2024-01-28T08:58:23+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74713490.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74856013.html 2024-11-13T15:00:32+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75180678.html 2024-02-22T00:19:25+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75180680.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76267064.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77131005.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77991219.html 2024-11-13T15:00:32+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77991225.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79209781.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-asthma-model-79209782.html 2024-11-13T15:00:38+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79209783.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79209809.html 2024-11-13T15:00:36+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79209810.html 2024-11-13T15:00:37+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79570350.html 2024-11-13T15:00:44+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79570351.html 2024-11-13T15:00:45+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79570353.html 2024-11-13T15:00:36+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pk-strategies-of-pdc-79575657.html 2024-08-04T05:30:59+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79575662.html 2024-08-04T05:31:02+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79575663.html 2024-11-13T15:00:33+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79575666.html 2024-08-04T05:31:00+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79575667.html 2024-08-04T05:31:02+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79575668.html 2024-11-13T15:00:39+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79575669.html 2024-08-04T05:31:04+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79575670.html 2024-08-04T05:31:00+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79575671.html 2024-08-04T05:31:04+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79575672.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79575673.html 2024-08-04T05:31:03+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79575674.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79575675.html 2024-08-04T05:31:03+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79575676.html 2024-08-04T05:31:03+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79575677.html 2024-08-04T05:31:04+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79575678.html 2024-08-04T05:31:06+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79575679.html 2024-08-04T05:31:01+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79575680.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79575681.html 2024-11-13T15:00:43+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79575682.html 2024-11-13T15:00:45+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79575683.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79575684.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79575685.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79575686.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79575687.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79575688.html 2024-08-04T05:31:07+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79575689.html 2024-08-04T05:31:05+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79575690.html 2024-08-04T05:31:06+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79575691.html 2024-08-04T05:31:01+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79575692.html 2024-11-13T15:00:46+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79575693.html 2024-08-04T05:31:06+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79575694.html 2024-08-04T05:31:09+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79575695.html 2024-08-04T05:31:07+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79575696.html 2024-08-04T05:31:07+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79575697.html 2024-08-04T05:31:07+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79575699.html 2024-11-13T15:00:34+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/mrna-based-therapies-past-79575700.html 2024-08-04T05:31:02+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79575701.html 2024-08-04T05:31:13+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79575702.html 2024-08-04T05:31:09+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79575703.html 2024-08-04T05:31:10+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79575704.html 2024-08-04T05:31:13+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/mrna-based-therapies-present-79575705.html 2024-08-04T05:31:13+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79575706.html 2024-08-04T05:31:09+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79575707.html 2024-08-04T05:31:11+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79575708.html 2024-08-04T05:31:06+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/significance-principles-and-requirements-of-79575709.html 2024-11-13T15:00:33+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79575710.html 2024-08-07T08:44:38+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656506.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81341063.html 2024-11-13T15:00:37+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/convection-enhanced-delivery-81341064.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/human-disease-animal-models-81341065.html 2024-11-13T15:00:41+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81341066.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81341068.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81341069.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/animal-models-of-human-diseases-81341070.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81341071.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81341074.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81341110.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81341111.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/china-experimental-monkey-industry-81341112.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/compartment-pk-model-81341113.html 2024-11-13T15:00:49+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82395284.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82653584.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82653585.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82653586.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82653587.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82653588.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82653593.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82653594.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82653605.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82653862.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-82980140.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-82980147.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-82980148.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83976362.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83976363.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83976364.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83976365.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83976375.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83976378.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83976380.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83976382.html 2025-01-18T05:53:54+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83976396.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243109104296960.html 2025-02-26T19:57:38+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243109221393408.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295174597256192.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295174605939712.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295174653404160.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295174656091136.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/animal-models-for-womens-health-17295174685172736.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/membranous-nephropathy-model-17295174702277632.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295174730245120.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295174788539392.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295174795256832.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295174806103040.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295174823257088.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295174918579200.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295174922822656.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295174936290304.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295174970549248.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295174982493184.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295175161111552.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298355162276864.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374205729088512.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374205762806784.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374205786350592.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374205787890688.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374205811106816.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374205865190400.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374205867615232.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374205871612928.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374205946864640.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374206002111488.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374206013514752.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374206194230272.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17457755765416960.html 2025-07-25T14:39:04+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17457755769250816.html 2025-07-25T14:39:07+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17457755819828224.html 2025-07-25T14:39:12+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17457755824792576.html 2025-07-25T14:39:17+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17457755841504256.html 2025-07-25T14:39:19+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17457755858641920.html 2025-07-25T14:39:11+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17457755875992576.html 2025-07-25T14:39:19+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/key-considerations-for-dosing-volume-17457755927454720.html 2025-07-25T14:39:07+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17457756035277824.html 2025-07-25T14:39:18+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17457756178670592.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17457767150461952.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17457767167288320.html 2025-08-26T17:17:34+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17503201504322560.html 2025-08-26T17:17:34+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17503201510269952.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17503201671750656.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17503201747723264.html 2025-08-26T17:17:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-copd-model-17503201759175680.html 2025-08-26T17:17:33+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17503202084824064.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17533449125798912.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17533449138856960.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/the-importance-of-administration-volume-17533449169069056.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17533449199526912.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17533449386337280.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/brain-targeted-drug-delivery-17533489191330816.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17533489230078976.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17543708321489920.html 2025-10-08T10:39:50+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17563683587580928.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17660930438128640.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17660930450269184.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17660930497750016.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17660930547311616.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17660930606244864.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17660930693080064.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17660930697634816.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17660930755912704.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/rfp-template-for-nhp-studies-17660930838569984.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17660931003360256.html 2026-03-29T01:51:28+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/nhp-renal-biopsy-17660931833472000.html 2025-12-25T10:23:06+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674087773840384.html 2025-12-25T10:23:04+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674087776117760.html 2025-12-25T10:23:11+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674087804478464.html 2025-12-25T10:23:26+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674087846388736.html 2025-12-25T10:23:07+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674087893296128.html 2025-12-25T10:23:10+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674087921869824.html 2025-12-25T10:23:13+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674088127996928.html 2025-12-25T10:43:51+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674098894889984.html 2025-12-25T10:43:33+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674098938487808.html 2026-01-29T18:23:42+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724106591773696.html 2026-01-29T18:24:03+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724106817152000.html 2026-01-29T18:23:30+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724107012023296.html 2026-01-29T18:23:37+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724107026785280.html 2026-01-29T18:23:35+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724107120190464.html 2026-01-29T18:23:29+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724107195065344.html 2026-01-29T18:23:35+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724107215365120.html 2026-01-29T18:24:00+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724107215774720.html 2026-01-29T18:23:35+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724107727692800.html 2026-01-29T18:23:41+08:00 weekly 0.8 https://ht.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724107809350656.html